Evidence map›Paper›PMID 24744699›Full record

ArticleFrontiers in cellular neuroscience2014

Regulating amyloidogenesis through the natural triggering receptor expressed in myeloid/microglial cells 2 (TREM2).

Brandon M Jones, Surjyadipta Bhattacharjee, Prerna Dua, James M Hill, Yuhai Zhao, Walter J Lukiw

Abstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Microbial-generated amyloids and Alzheimer's disease (AD).Frontiers in aging neuroscience · 2015
    Article
  15. Article
  16. 2015: which new directions for Alzheimer's disease?Frontiers in cellular neuroscience · 2014
    Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Brandon M JonesLSU Neuroscience Center, Louisiana State University Health Sciences Center (LSUHSC) New Orleans, LA, USA.
Surjyadipta BhattacharjeeLSU Neuroscience Center, Louisiana State University Health Sciences Center (LSUHSC) New Orleans, LA, USA.
Prerna DuaDepartment of Health Information Management, Louisiana State University Ruston, LA, USA.
James M HillLSU Neuroscience Center, Louisiana State University Health Sciences Center (LSUHSC) New Orleans, LA, USA ; Department of Ophthalmology, Health Sciences Center, Louisiana State University New Orleans, LA, USA.
Yuhai ZhaoDepartment of Ophthalmology, Health Sciences Center, Louisiana State University New Orleans, LA, USA.
Walter J LukiwLSU Neuroscience Center, Louisiana State University Health Sciences Center (LSUHSC) New Orleans, LA, USA ; Department of Ophthalmology, Health Sciences Center, Louisiana State University New Orleans, LA, USA ; Department of Neurology, Health Sciences Center, Louisiana State University New Orleans, LA, USA.

Funding

VISUAL AND ANALYTICAL TOOLS FOR CLUSTER ANALYSISP20RR016456 · NCRR · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI FENG, JUNE · 2001 to 2011
$28.7M
OCULAR HSV: LATENCY, REACTIVATION, &RECURRENCER01EY006311 · NEI · LSU HEALTH SCIENCES CENTER · PI HILL, JAMES M · 1985 to 2012
$5.3M
microRNA (miRNA) signaling in Alzheimer's disease(AD)R01AG038834 · NIA · LSU HEALTH SCIENCES CENTER · PI BAZAN, NICOLAS G. · 2011 to 2020
$3.3M
NCRR NIH HHS P20 RR016456NEI NIH HHS R01 EY006311NIA NIH HHS R01 AG038834
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer's disease (AD)amyloidogenesisAß42 peptidesinflammationmicroglial cellsmiRNA-34aphagocytosisTREM2

Identifiers

PMID24744699
PMCPMC3978349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.